A newly developed extract (Ze 339) from butterbur (Petasites hybridus L.) is clinically efficient in allergic rhinitis (hay fever)

Phytomedicine ◽  
2003 ◽  
Vol 10 ◽  
pp. 50-52 ◽  
Author(s):  
Axel Brattström
Keyword(s):  
Allergic Rhinitis ◽  
Hay Fever

Clinical verification in homeopathy and allergic conditions

Homeopathy ◽  
2013 ◽  
Vol 102 (01) ◽  
pp. 54-58 ◽  
Author(s):  
Michel Van Wassenhoven
Keyword(s):  
Allergic Rhinitis ◽  
Skin Diseases ◽  
Meta Analysis ◽  
Hay Fever ◽  
Care Practice ◽  
Homeopathic Medicine ◽  
Asthma Patients ◽  
Randomised Controlled ◽  
Clinical Verification

Background: The literature on clinical research in allergic conditions treated with homeopathy includes a meta-analysis of randomised controlled trials (RCT) for hay fever with positive conclusions and two positive RCTs in asthma. Cohort surveys using validated Quality of Life questionnaires have shown improvement in asthma in children, general allergic conditions and skin diseases. Economic surveys have shown positive results in eczema, allergy, seasonal allergic rhinitis, asthma, food allergy and chronic allergic rhinitis. Aims: This paper reports clinical verification of homeopathic symptoms in all patients and especially in various allergic conditions in my own primary care practice. Results: For preventive treatments in hay fever patients, Arsenicum album was the most effective homeopathic medicine followed by Nux vomica, Pulsatilla pratensis, Gelsemium, Sarsaparilla, Silicea and Natrum muriaticum. For asthma patients, Arsenicum iodatum appeared most effective, followed by Lachesis, Calcarea arsenicosa, Carbo vegetabilis and Silicea. For eczema and urticaria, Mezereum was most effective, followed by Lycopodium, Sepia, Arsenicum iodatum, Calcarea carbonica and Psorinum. Conclusions: The choice of homeopathic medicine depends on the presence of other associated symptoms and ‘constitutional’ features. Repertories should be updated by including results of such clinical verifications of homeopathic prescribing symptoms.

Citizen science based symptom scores of allergic rhinitis to validate the grass pollen hay fever forecast

2015 ◽  
Author(s):  
Letty A. De Weger ◽  
H. Bas Hofstee ◽  
Arnold J.H. Van Vliet ◽  
Pieter S. Hiemstra ◽  
Jacob K. Sont
Keyword(s):  
Allergic Rhinitis ◽  
Citizen Science ◽  
Grass Pollen ◽  
Hay Fever ◽  
Symptom Scores

scholarly journals ArtemisiaAllergy Research in China

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Rui Tang ◽  
Jin-Lu Sun ◽  
Jia Yin ◽  
Zhi Li
Keyword(s):  
Allergic Rhinitis ◽  
Oral Immunotherapy ◽  
Hay Fever ◽  
Allergenic Pollen ◽  
Asthma Diagnosis ◽  
Allergen Components ◽  
Immunological Changes ◽  
Double Blinded ◽  
Published Research ◽  
Blinded Trial

Artemisiais the most important outdoor allergen throughout China. It can cause allergic rhinitis, asthma, or both of them. Since it was verified as an allergenic pollen in 1960, it was identified two times in the Chinese National Pollen Survey (1984, 2009). The first oral immunotherapy double-blinded trial forArtemisiapollen asthma research was conducted in China in 1989 and published in 1990. 40 years since that study, there have been many published research reports on ChineseArtemisiaallergy. This review summarizes the information regarding the discovery ofArtemisiaas an allergenic pollen, pollen account, epidemiology, allergen components, immunological changes in hay fever patients, natural course from rhinitis to asthma, diagnosis, and immunotherapies in China.

Additional Disease Burden from Hay Fever and Sinusitis Accompanying Asthma

2009 ◽  
Vol 118 (9) ◽  
pp. 651-655 ◽  
Author(s):  
Neil Bhattacharyya ◽  
Lynn J. Kepnes
Keyword(s):  
Health Care ◽  
Allergic Rhinitis ◽  
Emergency Room ◽  
National Health Interview Survey ◽  
Disease Burden ◽  
Health Care Expenditures ◽  
Hay Fever ◽  
Health Care Spending ◽  
Emergency Room Visits ◽  
Interview Survey

Objectives: We sought to determine the additional disease burden imparted by sinusitis and hay fever (allergic rhinitis) to patients with asthma. Methods: Patients with a diagnosis of asthma, hay fever, or sinusitis were extracted from the National Health Interview Survey for the 1997 to 2006 adult sample. Disease groups consisting of patients with asthma alone, asthma + hay fever, asthma + sinusitis, and asthma + hay fever + sinusitis were assembled. Disease groups were then compared according to total health-care visits per year, emergency room visits per year, health-care spending per year, and number of workdays lost per year to determine the disease burden. Results: We identified 11,813 patients (mean age, 45.5 years) who reported active asthma with or without hay fever or sinusitis comorbidity. Of these, 5,931 patients (50%) were identified with asthma alone, 1,134 (10%) with combined asthma + hay fever, 2,461 (21%) with asthma + sinusitis, and 2,287 (19%) with combined asthma + hay fever + sinusitis. Patients with asthma + sinusitis and those with asthma + sinusitis + hay fever had more total health-care visits and emergency room visits than did those with asthma alone (p < 0.001). All three groups with comorbidities had higher health-care expenditures than did the group with asthma alone (p ≤ 0.002). Patients with asthma + sinusitis and those with asthma + hay fever + sinusitis missed more workdays than did patients in the group with asthma alone (10.0 and 13.1 versus 7.2, respectively; p < 0.001). Comorbid hay fever alone did not increase workdays lost (6.6 days; p = 0.983). Conclusions: The additional disease burden of sinusitis on asthma is greater than that of hay fever. These data highlight the importance of identifying comorbid diagnoses with asthma.

scholarly journals Nasal hyperreactivity and inflammation in allergic rhinitis

1996 ◽  
Vol 5 (2) ◽  
pp. 79-94 ◽  
Author(s):  
I. M. Garrelds ◽  
C. de Graaf-in't Veld ◽  
R. Gerth van Wijk ◽  
F. J. Zijlstra
Keyword(s):  
Allergic Rhinitis ◽  
Clinical Manifestations ◽  
Allergic Inflammation ◽  
Inflammatory Cells ◽  
Hay Fever ◽  
Effector Cells ◽  
Plasma Exudation ◽  
History Of ◽  
Definition Of ◽  
Antigen Presenting

The history of allergic disease goes back to 1819, when Bostock described his own ‘periodical affection of the eyes and chest’, which he called ‘summer catarrh’. Since they thought it was produced by the effluvium of new hay, this condition was also called hay fever. Later, in 1873, Blackley established that pollen played an important role in the causation of hay fever. Nowadays, the definition of allergy is ‘An untoward physiologic event mediated by a variety of different immunologic reactions’. In this review, the term allergy will be restricted to the IgE-dependent reactions. The most important clinical manifestations of IgE-dependent reactions are allergic conjunctivitis, allergic rhinitis, allergic asthma and atopic dermatitis. However, this review will be restricted to allergic rhinitis. The histopathological features of allergic inflammation involve an increase in blood flow and vascular permeability, leading to plasma exudation and the formation of oedema. In addition, a cascade of events occurs which involves a variety of inflammatory cells. These inflammatory cells migrate under the influence of chemotactic agents to the site of injury and induce the process of repair. Several types of inflammatory cells have been implicated in the pathogenesis of allergic rhinitis. After specific or nonspecific stimuli, inflammatory mediators are generated from cells normally found in the nose, such as mast cells, antigen-presenting cells and epithelial cells (primary effector cells) and from cells recruited into the nose, such as basophils, eosinophils, lymphocytes, platelets and neutrophils (secondary effector cells). This review describes the identification of each of the inflammatory cells and their mediators which play a role in the perennial allergic processes in the nose of rhinitis patients.

Sign in / Sign up

Export Citation Format

Share Document